Guided Therapeutics (GTHP) Preferred Shares (2013 - 2025)
Guided Therapeutics recorded quarterly Preferred Shares of $18000.0 in Q4 2025, down 43.75% quarter-over-quarter from $32000.0 in Q2 2025, and down 89.41% year-over-year from $170000.0 in Q4 2024.
Guided Therapeutics' Preferred Shares history runs 13 years deep, the most recent figure standing at $18000.0 for Q4 2025.
- In Q4 2025, Preferred Shares fell 89.41% year-over-year to $18000.0; the TTM figure through Dec 2025 stood at $18000.0 (down 89.41% YoY), while the FY2025 annual figure was $18000.0, down 89.41% from the prior year.
- Preferred Shares came in at $18000.0 for Q4 2025 at Guided Therapeutics, down from $32000.0 in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $1.6 million in Q4 2021 to a low of $18000.0 in Q4 2025.
- A 5-year average of $471684.2 and a median of $475000.0 in 2023 frame the typical range for Preferred Shares.
- Across the five-year window, Preferred Shares surged 698.1% in 2023 and slumped 93.26% in 2025, its largest moves.
- Guided Therapeutics' Preferred Shares stood at $1.6 million in 2021, then sank by 70.16% to $489000.0 in 2022, then jumped by 71.37% to $838000.0 in 2023, then slumped by 79.71% to $170000.0 in 2024, then slumped by 89.41% to $18000.0 in 2025.
- According to Business Quant data, Preferred Shares over the past three periods registered $18000.0, $32000.0, and $61000.0 for Q4 2025, Q2 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Guided Therapeutics | - | - | 458,000.00 | 18,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18,000.00 |
| Jun 30, 2025 | 32,000.00 |
| Mar 31, 2025 | 61,000.00 |
| Dec 31, 2024 | 170,000.00 |
| Sep 30, 2024 | 834,000.00 |
| Jun 30, 2024 | 475,000.00 |
| Mar 31, 2024 | 838,000.00 |
| Dec 31, 2023 | 838,000.00 |
| Sep 30, 2023 | 834,000.00 |
| Jun 30, 2023 | 838,000.00 |
| Mar 31, 2023 | 475,000.00 |
| Dec 31, 2022 | 489,000.00 |
| Sep 30, 2022 | 489,000.00 |
| Jun 30, 2022 | 105,000.00 |
| Mar 31, 2022 | 276,000.00 |
| Dec 31, 2021 | 1.64 Mn |
| Sep 30, 2021 | 170,000.00 |
| Jun 30, 2021 | 105,000.00 |
| Mar 31, 2021 | 276,000.00 |
| Dec 31, 2020 | 276,000.00 |
| Sep 30, 2020 | 170,000.00 |
| Jun 30, 2020 | 170,000.00 |
| Sep 30, 2019 | 170,000.00 |
| Jun 30, 2019 | 170,000.00 |
| Mar 31, 2019 | 531,000.00 |
| Dec 31, 2018 | 105,000.00 |
| Sep 30, 2018 | 105,000.00 |
| Jun 30, 2018 | 120,000.00 |
| Mar 31, 2018 | 251,000.00 |
| Dec 31, 2017 | 355,000.00 |
| Sep 30, 2017 | 431,000.00 |
| Jun 30, 2017 | 701,000.00 |
| Mar 31, 2017 | 701,000.00 |
| Dec 31, 2016 | 601,000.00 |
| Sep 30, 2016 | 701,000.00 |
| Dec 31, 2015 | 2.05 Mn |
| Jun 30, 2015 | 678,000.00 |
| Mar 31, 2015 | 678,000.00 |
| Dec 31, 2014 | 678,000.00 |
| Sep 30, 2014 | 678,000.00 |
| Jun 30, 2014 | 813,000.00 |
| Mar 31, 2014 | 922,000.00 |
| Dec 31, 2013 | 1.14 Mn |
| Sep 30, 2013 | 1.30 Mn |
| Jun 30, 2013 | 1.34 Mn |